Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 25 studies | 42% ± 21% | |
fibroblast | 17 studies | 36% ± 20% | |
pericyte | 17 studies | 39% ± 22% | |
astrocyte | 16 studies | 48% ± 21% | |
oligodendrocyte | 15 studies | 59% ± 16% | |
oligodendrocyte precursor cell | 14 studies | 71% ± 22% | |
glutamatergic neuron | 13 studies | 74% ± 22% | |
ciliated cell | 12 studies | 39% ± 21% | |
GABAergic neuron | 10 studies | 67% ± 21% | |
endothelial cell | 10 studies | 46% ± 21% | |
neuron | 9 studies | 41% ± 20% | |
retinal rod cell | 9 studies | 67% ± 30% | |
microglial cell | 9 studies | 38% ± 22% | |
adipocyte | 9 studies | 82% ± 12% | |
retinal cone cell | 7 studies | 76% ± 24% | |
macrophage | 6 studies | 28% ± 12% | |
interneuron | 6 studies | 60% ± 26% | |
type I pneumocyte | 6 studies | 48% ± 8% | |
cardiac muscle cell | 6 studies | 87% ± 13% | |
mesothelial cell | 5 studies | 32% ± 17% | |
glial cell | 5 studies | 40% ± 12% | |
epithelial cell | 5 studies | 29% ± 16% | |
type II pneumocyte | 5 studies | 25% ± 8% | |
myofibroblast cell | 5 studies | 34% ± 27% | |
Mueller cell | 4 studies | 34% ± 19% | |
respiratory goblet cell | 4 studies | 30% ± 16% | |
muscle cell | 4 studies | 57% ± 32% | |
club cell | 4 studies | 22% ± 7% | |
mast cell | 4 studies | 36% ± 25% | |
hepatic stellate cell | 3 studies | 59% ± 11% | |
T cell | 3 studies | 25% ± 9% | |
GABAergic interneuron | 3 studies | 67% ± 12% | |
Purkinje cell | 3 studies | 81% ± 10% | |
progenitor cell | 3 studies | 30% ± 10% | |
retinal pigment epithelial cell | 3 studies | 18% ± 1% | |
GABAergic amacrine cell | 3 studies | 36% ± 11% | |
OFF-bipolar cell | 3 studies | 69% ± 21% | |
basal cell | 3 studies | 27% ± 3% | |
hepatocyte | 3 studies | 57% ± 19% | |
abnormal cell | 3 studies | 31% ± 14% | |
ependymal cell | 3 studies | 66% ± 8% | |
Schwann cell | 3 studies | 45% ± 18% | |
melanocyte | 3 studies | 48% ± 21% | |
myoepithelial cell | 3 studies | 65% ± 35% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 85% | 1984.56 | 2236 / 2642 | 96% | 8.14 | 676 / 705 |
pancreas | 100% | 3374.38 | 327 / 328 | 66% | 2.92 | 117 / 178 |
prostate | 85% | 3196.31 | 209 / 245 | 79% | 5.40 | 398 / 502 |
thymus | 83% | 1822.34 | 545 / 653 | 80% | 11.94 | 481 / 605 |
adrenal gland | 95% | 2672.01 | 246 / 258 | 67% | 3.50 | 154 / 230 |
liver | 87% | 2556.81 | 196 / 226 | 74% | 4.53 | 299 / 406 |
breast | 97% | 3687.13 | 447 / 459 | 45% | 2.74 | 500 / 1118 |
stomach | 87% | 3580.77 | 313 / 359 | 53% | 3.36 | 152 / 286 |
uterus | 98% | 5651.34 | 166 / 170 | 34% | 3.18 | 154 / 459 |
skin | 69% | 1697.05 | 1242 / 1809 | 61% | 4.19 | 287 / 472 |
lung | 72% | 1479.00 | 416 / 578 | 51% | 3.16 | 584 / 1155 |
ovary | 97% | 3164.66 | 175 / 180 | 24% | 1.04 | 103 / 430 |
esophagus | 68% | 5117.93 | 983 / 1445 | 52% | 3.61 | 95 / 183 |
intestine | 80% | 7225.20 | 777 / 966 | 39% | 1.71 | 208 / 527 |
bladder | 86% | 6126.86 | 18 / 21 | 31% | 1.71 | 157 / 504 |
muscle | 100% | 14904.76 | 803 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 10661.48 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 3805.28 | 1174 / 1204 | 0% | 0 | 0 / 0 |
heart | 93% | 7297.29 | 797 / 861 | 0% | 0 | 0 / 0 |
kidney | 19% | 334.66 | 17 / 89 | 63% | 3.57 | 569 / 901 |
lymph node | 0% | 0 | 0 / 0 | 69% | 7.43 | 20 / 29 |
tonsil | 0% | 0 | 0 / 0 | 56% | 4.43 | 25 / 45 |
eye | 0% | 0 | 0 / 0 | 38% | 1.81 | 30 / 80 |
peripheral blood | 16% | 457.95 | 144 / 929 | 0% | 0 | 0 / 0 |
spleen | 0% | 5.71 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035994 | Biological process | response to muscle stretch |
GO_0007519 | Biological process | skeletal muscle tissue development |
GO_0046716 | Biological process | muscle cell cellular homeostasis |
GO_0055001 | Biological process | muscle cell development |
GO_0002027 | Biological process | regulation of heart rate |
GO_0043043 | Biological process | peptide biosynthetic process |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0086001 | Biological process | cardiac muscle cell action potential |
GO_0060048 | Biological process | cardiac muscle contraction |
GO_1901385 | Biological process | regulation of voltage-gated calcium channel activity |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0010881 | Biological process | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion |
GO_0090257 | Biological process | regulation of muscle system process |
GO_1902083 | Biological process | negative regulation of peptidyl-cysteine S-nitrosylation |
GO_0048666 | Biological process | neuron development |
GO_0007517 | Biological process | muscle organ development |
GO_2000651 | Biological process | positive regulation of sodium ion transmembrane transporter activity |
GO_0035633 | Biological process | maintenance of blood-brain barrier |
GO_0099536 | Biological process | synaptic signaling |
GO_0014819 | Biological process | regulation of skeletal muscle contraction |
GO_0008104 | Biological process | protein localization |
GO_0010880 | Biological process | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
GO_0033137 | Biological process | negative regulation of peptidyl-serine phosphorylation |
GO_0014809 | Biological process | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion |
GO_0060314 | Biological process | regulation of ryanodine-sensitive calcium-release channel activity |
GO_0005856 | Cellular component | cytoskeleton |
GO_0030055 | Cellular component | cell-substrate junction |
GO_0016013 | Cellular component | syntrophin complex |
GO_0045121 | Cellular component | membrane raft |
GO_0030018 | Cellular component | Z disc |
GO_0043034 | Cellular component | costamere |
GO_0032991 | Cellular component | protein-containing complex |
GO_0042383 | Cellular component | sarcolemma |
GO_0016010 | Cellular component | dystrophin-associated glycoprotein complex |
GO_0031527 | Cellular component | filopodium membrane |
GO_0009986 | Cellular component | cell surface |
GO_0030175 | Cellular component | filopodium |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0044306 | Cellular component | neuron projection terminus |
GO_0008307 | Molecular function | structural constituent of muscle |
GO_0017022 | Molecular function | myosin binding |
GO_0005200 | Molecular function | structural constituent of cytoskeleton |
GO_0050998 | Molecular function | nitric-oxide synthase binding |
GO_0002162 | Molecular function | dystroglycan binding |
GO_0017166 | Molecular function | vinculin binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | DMD |
Protein name | Dystrophin isoform 2 DMD protein Duchenne muscular dystrophy gene (Dystrophin) Truncated dystrophin protein Duchenne muscular dystrophy protein (Dystrophin) Alternative protein DMD DMD protein (Dystrophin) Dystrophin Dystrophin isoform 6 Dystrophin isoform 4 (cDNA FLJ60143, highly similar to Homo sapiens dystrophin, transcript variant Dp140bc, mRNA) Dystrophin isoform 1 |
Synonyms | dystrophin |
Description | FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. . |
Accessions | Q8WYF4 A0A5H1ZRQ1 ENST00000680768.2 ENST00000681334.1 Q8WYC0 A0A0S2Z3B5 Q8WYD2 ENST00000343523.7 A0A7P0Z4P7 Q8WYD3 L8E939 A0A7P0TBK1 ENST00000681839.1 P11532 A0A804HKZ5 ENST00000680961.1 A0A7P0Z4M9 ENST00000420596.5 A0A087WTU7 A0A804HL39 ENST00000378707.7 Q6PK12 A0A7P0TA90 A0A7P0Z447 Q8WYD0 A0A6B9W032 B4DSV7 A0A7P0Z4Q6 H0Y304 A0A7P0TAD9 ENST00000681870.1 ENST00000471779.1 Q9UPB5 ENST00000682322.1 ENST00000447523.1 ENST00000682924.1 Q8WYB8 Q8WYF2 ENST00000619831.5 Q8WYF5 ENST00000684237.1 ENST00000682600.1 [P11532-8] Q8WYE1 Q8WYE6 Q9UMK6 ENST00000684130.1 ENST00000680557.1 Q8WYC9 ENST00000359836.5 Q8WYB7 H0Y864 ENST00000679437.1 ENST00000681153.1 Q8WYC3 A7E212 F2WSI7 ENST00000378680.6 [P11532-9] Q8WYC1 A0A7P0TAX0 ENST00000357033.9 Q9UME2 A0A0S2Z3M6 A0A5H1ZRQ8 Q15945 ENST00000358062.7 A0A5H1ZRP8 A0A087WV90 ENST00000448370.5 Q9UMG1 ENST00000680216.1 Q8WYF1 A0A804HKY9 A0A804HJY0 A0A0S2Z3B2 A0A075B6G3 Q8WYE5 Q14172 Q548X2 F1CFE6 Q8WYE0 A0A0C4DH61 ENST00000378677.6 Q8WYC8 Q8WYD9 A0A6B9VZT5 Q8WYE7 Q9UMK8 A0A5H1ZRP9 Q8WYD4 ENST00000288447.9 ENST00000541735.5 Q9UMK7 A0A6B9W2D0 L8ECA9 Q9UEH4 ENST00000680162.2 A0A0B4J1W6 A0A804HIY5 A0A5H1ZRR9 A0A0S2Z3J7 Q8WYE4 ENST00000682238.1 A0A7P0TAW7 Q8WYD5 Q9UPB4 A0A7P0T8I2 Q14174 A0A7P0TAM6 A0A7D5DCA8 ENST00000681026.1 Q8WYD1 Q8WYE9 H0Y3E8 A0A5H1ZRP7 ENST00000680355.1 Q4G0X0 Q8WYE2 Q8WYC4 Q8WYE3 Q8WYC6 A0A7L5NSL0 Q8WYE8 ENST00000620040.5 Q7KZ40 Q8WYD7 Q16484 Q8WYD6 Q8WYD8 A0A7P0TB71 Q8WYF0 ENST00000361471.8 [P11532-5] A0A804HKR4 ENST00000679706.1 Q8WYF3 Q8TCV2 Q8WTQ2 ENST00000474231.5 ENST00000378705.3 ENST00000679641.1 A0A6B9W0D6 Q8WYB9 Q8WYC7 Q8WYC5 Q8WTT4 Q8WYF6 Q8WYC2 ENST00000493412.1 ENST00000378723.7 [P11532-6] ENST00000378702.8 [P11532-7] ENST00000682071.1 |